Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06745947 · ClinicalTrials.gov registry record · NA

Behavioral Economic Intervention to Improve HIV Behaviors in Sexual Minority Individuals

A NA study of HIV Prevention, sponsored by The University of Texas Health Science Center at San Antonio.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT06745947: Recruiting NA study of HIV Prevention, sponsored by The University of Texas Health Science Center at San Antonio.

NCT06745947 is a NA study of HIV Prevention that is actively recruiting participants, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 60 participants, below the 380-participant average among 32 other HIV Prevention trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06745947, a NA study of HIV Prevention, is actively recruiting participants, sponsored by The University of Texas Health Science Center at San Antonio.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

This research study is testing a new behavioral therapy called Episodic Future Thinking or EFT can help people reduce drug use and risky sexual behaviors while helping them adhere to their HIV prevention medication (PrEP). Participants will be randomly assigned to one of two groups. One group will receive standard care, which includes counseling on HIV prevention, drug use reduction, and sexual health. The other group will receive standard care plus a new program called Episodic Future Thinking (EFT), where participants will think about and plan for their future goals using a mobile app and counseling sessions. Study procedures that are not part of regular care include filling out surveys, providing blood, urine, and swab samples for testing, and using the EFT app.

Primary Outcome

Blood spots will be collected and assessed for PrEP adherence. Number of subjects adhering to PrEP will be reported.

Conditions Studied

Interventions

  • BEHAVIORAL EFT

Study Locations (1)

Texas

  • University of Texas Health Science Center at San Antonio - San Antonio

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2025-03-03
Est. Completion 2027-07-01
Phase NA

What NCT06745947 shows while recruiting

NCT06745947 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 380-participant average among 32 other HIV Prevention trials with a reported enrollment target (84% lower).

The record links to 1 condition, with HIV Prevention appearing as the primary indexed condition, and to 1 intervention - of which EFT is the first listed.

NCT06745947 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT06745947 about?

NCT06745947 is a clinical study titled "Behavioral Economic Intervention to Improve HIV Behaviors in Sexual Minority Individuals". This research study is testing a new behavioral therapy called Episodic Future Thinking or EFT can help people reduce drug use and risky sexual behaviors while helping them adhere to their HIV prevention medication (PrEP). Participants will be randomly assigned to one of two groups. One group will r...

What is the current status of trial NCT06745947?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-03-03. Estimated completion is 2027-07-01.

What conditions does trial NCT06745947 study?

This clinical trial studies the following conditions: HIV Prevention.

What interventions are being tested in trial NCT06745947?

The interventions under investigation include: EFT (BEHAVIORAL).

Who is sponsoring clinical trial NCT06745947?

This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06745947 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV Prevention

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06745947's enrollment target sits among peer trials

60 25th of 32 higher than 8 of 32 other HIV Prevention trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other HIV Prevention trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06745947, the US trial registry maintained by the National Library of Medicine. NCT06745947 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.